Group One Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-500
| Closed | -$2K | – | 5703 |
|
|
2019
Q1 | $2K | Buy |
+500
| New | +$2.17K | ﹤0.01% | 4633 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$6K | – | 5772 |
|
|
2018
Q3 | $6K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 4806 |
|
|
2018
Q2 | – | Sell |
-15,600
| Closed | -$69K | – | 5713 |
|
|
2018
Q1 | $69K | Buy |
15,600
+8,000
| +105% | +$35.7K | ﹤0.01% | 3491 |
|
|
2017
Q4 | $40K | Buy |
7,600
+3,100
| +69% | +$19K | ﹤0.01% | 3845 |
|
|
2017
Q3 | $28K | Sell |
4,500
-12,400
| -73% | -$78.5K | ﹤0.01% | 3921 |
|
|
2017
Q2 | $122K | Sell |
16,900
-65,200
| -79% | -$401K | ﹤0.01% | 2994 |
|
|
2017
Q1 | $435K | Buy |
+82,100
| New | +$554K | 0.01% | 1933 |
|
|
2016
Q2 | – | Sell |
-200
| Closed | -$1K | – | 5129 |
|
|
2016
Q1 | $1K | Buy |
+200
| New | +$752 | ﹤0.01% | 4473 |
|
|
2015
Q4 | – | Sell |
-1,000
| Closed | -$8K | – | 5337 |
|
|
2015
Q3 | $8K | Sell |
1,000
-1,000
| -50% | -$16.9K | ﹤0.01% | 4387 |
|
|
2015
Q2 | $30K | Buy |
+2,000
| New | +$28.9K | ﹤0.01% | 3844 |
|
|
2014
Q4 | – | Sell |
-500
| Closed | -$5K | – | 5493 |
|
|
2014
Q3 | $5K | Sell |
500
-2,600
| -84% | -$31.5K | ﹤0.01% | 4748 |
|
|
2014
Q2 | $48K | Buy |
+3,100
| New | +$43.9K | ﹤0.01% | 3572 |
|
Other funds holding PETX
Group One Trading's PETX Position: Q3 2019 in Review
Group One Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,900 shares — an estimated $10K sold.
Group One Trading first reported a position in PETX in Q2 2014 and held it in 16 quarters. The position peaked at $395K in Q1 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Group One Trading reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Group One Trading sold 1,900 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $10K.
- Group One Trading first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 16 quarters.
- Group One Trading's Aratana Therapeutics, Inc. position peaked at $395K in Q1 2017.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.